Strategies for delivering local anesthetics to the skin: Focus on liposomes, solid lipid nanoparticles, hydrogels and patches

Expert Opinion on Drug Delivery

Volumn 10, Issue 11, 2013, Pages 1551-1563

  De Araújo, Daniele R ^a   Da Silva, Deyse C ^a   Barbosa, Raquel M ^b   Franz Montan, Michelle ^b   Cereda, Cíntia Ms ^b   Padula, Cristina ^c   Santi, Patrizia ^c   De Paula, Eneida ^b  

^a UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Hydrogels; Lipid nanoparticles; Liposomes; Local anesthetics; Patches; Skin.

Indexed keywords

BENZOCAINE; BUPIVACAINE; BUTYLCAINE; EMLA; LIDOCAINE; LIDOCAINE PLUS TETRACAINE; LIPOSOME; LOCAL ANESTHETIC AGENT; MEPIVACAINE; OXYBUPROCAINE; PENETRATION ENHANCING AGENT; PLACEBO; POLYETHERURETHAN; PRAMOCAINE; PROXYMETACAINE; ROPIVACAINE; SOLID LIPID NANOPARTICLE;

DRUG FORMULATION; HUMAN; HYDROGEL; LIPOSOMAL DELIVERY; MEMBRANE MODEL; PHYSICAL CHEMISTRY; REVIEW; SKIN STRUCTURE; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; GELS; HUMANS; HYDROGELS; LIPIDS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SKIN;

EID: 84886615915     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.828031     Document Type: Review

References (118)

1. Martin MD, Ramsay DS, Whitney C, et al. Topical anesthesia: differentiating the pharmacological and psychological contributions to efficacy. Anesth Prog 1994;41:40-7
2. Musawi AA, Andersson L. Use of topical as only anesthetic for suturing a traumatic facial laceration. Dent Traumatol 2010;26:292-3
3. Friedman PM, Fogelman JP, Nomi K, et al. Comparative study of the efficacy of four topical anesthetics. Dermatol Surg 1999;25:950-4
4. Friedman PM, Mafong EA, Friedman ES, et al. Topical anesthetics update:padula EMLA and beyond. Dermatol Surg 2001;27:1019-26
5. Tadirchela S, Berman B. Percutaneous dermal drug delivery for local pain control. Ther Clin Risk Manag 2006;2:99-113
6. Kundu S, Achar S. Principles of office anesthesia: part II. Topical anesthesia. Am Fam Phys 2002;66:99-102
7. Eichenfield LF, Funk A, Fallon-Friedlander S, et al. A clinical study to evaluate the efficacy of ELA-Max (4% Liposomal Lidocaine) as compared with eutectic mixture of local anesthetics cream for pain reduction of venipuncture in children. Pediatrics 2002;109:1093-9
8. Koh JL, Harrison D, Myers R, et al. A randomized, double-blind comparison study of EMLA and ELA-Max for topical anesthesia in children undergoing intravenous insertion. Pediatr Anaesth 2004;14:977-82
9. Mura P, Maestrelli F, González-Rodŕguez ML, et al. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 2007;67:86-95
10. Maestrelli F, Capasso G, González-Rodŕguez ML, et al. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009;19:253-60
11. Zhu X, Li F, Peng X, Zeng K. Formulation and Evaluation of Lidocaine Base Ethosomes for Transdermal Delivery. Anesth Analg 2013;117(2):352-7
12. Changez M, Chander J, Dinda AK. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Coll Surf B: Biointerfaces 2006;48:58-66
13. de Araujo DR, Padula C, Cereda CM, et al. Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect. Pharm Res 2010;27:1677-86
14. Fraczec M, Demidas A. Assessment of the efficacy of topical anesthetics using tactile spatial resolution method. Acta Dermatovenerol Croat 2012;20:7-13
15. Eildman A, Weiis JM, Lau J, et al. Topical anesthetics for dermal instrumentation: a systematic review of randomized, controlled trials. Ann Emerg Med 2005;46:343-51
16. Singer AJ, Shallat J, Valentine SM, et al. Cutaneous tape stripping to accelerate the anesthetic effects of EMLA cream: a randomized, controlled trial. Acad Emerg Med 1998;5(11):1051-6
17. Padula C, Colombo G, Nicoli S, et al. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release 2003;88(2):277-85
18. Padula C, Fulgoni A, Santi P. In vivo stratum corneum distribution of lidocaine, assessed by tape stripping, from a new bioadhesive film. Skin Res Tech 2010;16:125-30
19. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, et al. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1-36
20. Bouwstra JA, Gooris G, Ponec M. The lipid organization of the skin barrier: liquid and crystalline domains coexist in lamellar phases. J Biol Phys 2002;28:211-23
21. Hatta I, Ohta N, Inoue K, et al. Coexistence of two domains in intercellular lipid matrix of stratum corneum. Biochim Biophys Acta 2006;1758:1830-6
22. Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007;59:1152-61
23. Kalia YN, Guy R. Modeling transdermal drug release. Adv Drug Deliv Rev 2001;48:159-72
24. de Jong RH. Local anesthetics. Springfield; Illinois: 1994
25. De Paula E, Schreier S. Molecular and physicochemical aspects of local anesthetic-membrane interaction. Braz J Med Biol Res 1996;29:877-94
26. De Paula E, Schreier S. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta 1995;1240:25-33
27. Torchilin VP. Liposomes in drug delivery. In: Siegel RA, Rathbone MJ, editors. Drug delivery, advances in delivery science and technology. Control Rel Soc, New York; 2012;11:289-328
28. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297-305
29. Lichtenberg D, Barenholz Y. Liposomes: preparation, characterization and preservation. Meth Biochem Anal 1988;33:337-62
30. Ranade VV. Drug delivery systems. Site-specific drug delivery using liposomes as carriers. J Clin Pharmacol 1989;29:685-94
31. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26:1473-7
32. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473-4
33. Lee S, Lee J, Choi YW. Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (Lipogel) formulation and electrical assistance. Biol Pharm Bull 2007;30:393-6
34. Elsayed MM, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 2007;332:1-16
35. de Paula E, Cereda CM, Tofoli GR, et al. Drug delivery systems for local anesthetics. Recent Pat Drug Deliv Formul 2010;4:23-34
36. Lasic DD. Recent development medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo. J Control Rel 1997;48:203-22
37. Bahia AP, Azevedo EG, Ferreira LA, et al. New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker. Eur J Pharm Sci 2010;39:90-6
38. Gillet A, Lecomte F, Hubert P, et al. Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 2011;70:43-53
39. Neubert RHH. Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm 2011;77:1-2
40. Kirjavainen M, Urtti A, Jaaskelainen I, et al. Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta 1996;1304:179-89
41. Kirjavainen M, Urtti A, Valjakka-Koskela R, et al. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999;7:279-86
42. Mustafa MA, Elsayed OY, Abdallah VF, et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 2006;322:60-6
43. El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22
44. Hill MW. The effect of anaesthetic-like molecules on the phase transition in smetic mesophases of dipalmitoyllecithin I. The normal alcohol up to C=9 and three inhalation anaesthetics. Biochim Biophys Acta 1974;356:117-24
45. Fraceto LF, Spisni A, Schreier S, et al. Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by 1H-NMR measurements. Biophys Chem 2005;115:11-18
46. Suwalsky M, Schneider C, Villena F, et al. Structural effects of the local anesthetic bupivacaine hydrochloride on the human erythrocyte membrane and molecular models. Blood Cells Mol Dis 2002;29:14-23
47. Cereda CM, de Araujo DR, Brunetto GB, et al. Liposomal prilocaine: preparation, characterization, and in vivo evaluation. J Pharm Pharm Sci 2004;7:235-40
48. Pinto LM, Yokaichiya DK, Fraceto LF, et al. Interaction of benzocaine with model membranes. Biophys Chem 2000;87:213-23
49. Kuroda Y, Nasu H, Fujiwara Y, et al. Orientations and locations of local anesthetics Benzocaine and Butamben in phospholipid membranes as studied by 2H NMR spectroscopy. J Membr Biol 2000;177:117-28
50. Cabeça LF, Pickholz M, de Paula E, et al. Liposome-prilocaine interaction mapping evaluated through STD NMR and molecular dynamics simulations. J Phys Chem B 2009;113:2365-70
51. Cereda CM, Franz-Montan M, da Silva CM, et al. Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res 2013;23(3):228-34
52. Wang Y, Su W, Li Q, et al. Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery. 2013;441:748-56
53. Li L, Zhang Y, Han S, et al. Penetration enhancement of lidocaine hydrochlorid by a novel chitosan coated elastic liposome for transdermal drug delivery. J Biomed Nanotechnol 2011;7:704-13
54. Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002;54:S41-55
55. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, et al. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1-36
56. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675-711
57. Shim J, Kim MJ, Kim H-K, et al. Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes. Int J Pharm 2010;388:251-6
58. Bucalo BD, Mirikitani EJ, Moy RL. Comparison of skin anesthetic effect of liposomal lidocaine, nonliposomal lidocaine, and EMLA using 30-minute application time. Dermatol Surg 1998;24:537-41
59. Hung OR, Comeau L, Riley M, et al. Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine. Can J Anaesth 1997;44:707-11
60. Fisher R, Hung O, Mezei M, et al. Topical anesthesia of intact skin: liposome-encapsulated tetracaine vs. EMLA. Br J Anaesth 1998;81:972-3
61. Taddio A, Soin HK, Schuh S, et al. Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ 2005;172:1691-5
62. Singh R, Vyas SP. Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci 1996;13:107-11
63. Maestrelli F, González-Rodŕguez ML, Rabasco AM, et al. New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm 2010;395:222-31
64. Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257-72
65. Attama AA. SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat Drug Deliv Formul 2011;5:178-87
66. Severino P, Andreani T, Macedo AS, et al. Current State of Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. J Drug Deliv 2012;2012:1-10
67. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:131-55
68. Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011;8:1407-24
69. Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012;9:497-508
70. Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9:429-41
71. Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149-55
72. Müller RH, Shegokar R, Keck CM. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 2011;8:207-27
73. Puglia C, Sarpietro MG, Bonina F, et al. Development, characterization, and in vitro and in vivo evaluation of benzocaine and lidocaine loaded nanostructrured lipid carriers. J Pharm Sci 2011;100:1892-9
74. Wissing S, Saupe A, Muller R. Nanostructured lipid carriers (NLC) for topical use-an overview. Eurocosmetics 2003;5:14-17
75. Elnaggar YS, El-Massik MA, Abdallah OY. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine 2011;6:3195-205
76. Fonte P, Andrade F, Ara-ujo F, et al. Chitosan-coated solid lipid nanoparticles for insulin delivery. Methods Enzymol 2012;508:295-314
77. Patel PA, Patravale VB. AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J Biomed Nanotechnol 2011;7:632-9
78. Battaglia L, Serpe L, Muntoni E, et al. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Nanomedicine 2011;6:1561-73
79. Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 1999;16:205-13
80. Pathak P, Nagarsenker M. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech 2009;10:985-92
81. Barbosa RM, Casadei BR, da Silva CMG, et al. Spin label and SAXS study of cetylpalmitate solid lipid nanoparticles loaded with dibucaine. Biophys J 2013;104:344
82. Casadei BR, Barbosa RM, Marcato PD, et al. Structural effects of dibucaine encapsulation into solid lipid nanoparticles and nanostructured lipid carriers. Biophys J 2013;104:344
83. Barbosa RM, da Silva CMG, Bella TS, et al. Cytotoxicity of solid lipid nanoparticles and nanostructured lipid carriers containing the local anesthetic dibucaine designed for topical application. J Phys Conf Series 2013;429:012035
84. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008;60:1638-49
85. Bhattarai N, Gunn J, Zhang MQ. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010;62:83-99
86. Van Tomme SR, Storm G, Hennik WE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm 2008;355:1-18
87. Langer RS, Peppas NA. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981;2:201-14
88. Sivakumaran D, Maitland D, Hoare T. Injectable microgel-hydrogel composites for prolonged small-molecule drug delivery. Biomacromolecules 2011;12:4112-20
89. Galaev IY, Mattiasson B. 'Smart' polymers and what they could do in biotechnology and medicine. Trends Biotechnol 1999;17:335-40
90. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68:34-45
91. Gong C, Shi S, Wu L, et al. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior. Acta Biomater 2009;5:3358-70
92. Cohen R, Kanaan H, Grant GJ, et al. Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability. J Contr Rel 2012;160:346-52
93. Jin WG, Shin SC. Preparation and evaluation of procaine gels for the enhanced local anesthetic action. Arch Pharm Res 2008;31:235-41
94. Loughlin RG, Tunney MM, Donnelly RF, et al. Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur J Pharm Biopharm 2008;69:1135-46
95. McCarron PA, Murphy DJ, Little C, et al. Preliminary clinical assessment of polyvinyl alcohol-tetrahydroxyborate hydrogels as potential topical formulations for local anesthesia of lacerations. Acad Emerg Med 2011;18:333-9
96. Murphy DJ, Sankalia MG, Loughlin RG, et al. Physical characterisation and component release of poly(vinyl alcohol)-tetrahydroxyborate hydrogels and their applicability as potential topical drug delivery systems. Int J Pharm 2012;423:326-34
97. de Paula E, Cereda CMS, Fraceto LF, et al. Micro and Nanosystem for delivering local anesthetics. Exp Op Drug Del 2012;9:1505-24
98. Padula C, Nicoli S, Colombo P, et al. Single-layer transdermal film containing lidocaine: modulation of drug release. Eur J Pharm Biopharm 2007;66:422-8
99. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
100. Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-8
101. Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand 2011;123:295-309
102. Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin 2010;26:1607-19
103. Lin PL, Fan SZ, Huang CH, et al. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study. Reg Anesth Pain Med 2008;33:320-5
104. Campbell BJ, Rowbotham M, Davies PS, et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002;91:1343-50
105. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-40
106. Sabatowski R, Hans G, Tacken I, et al. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. Curr Med Res Opin 2012;28:1337-46
107. Nalamachu S, Crockett RS, Mathur D. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study. J Fam Pract 2006;55:209-14
108. Zink KA, Mayberry JC, Peck EG, et al. Lidocaine patches reduce pain in trauma patients with rib fractures. Am Surg 2011;77:438-42
109. Kim CH, Yoon JU, Lee HJ, et al. Availability of a 5% lidocaine patch used prophylactically for venipuncture-or injection-related pain in children. J Anesth 2012;26:552-5
110. Masud S, Wasnich RD, Ruckle JL, et al. Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. J Pain Symptom Manage 2010;40:510-19
111. Schecter AK, Pariser DM, Pariser RJ, et al. Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients. Dermatol Surg 2005;31:287-91
112. Curry SE, Finkel JC. Use of the Synera patch for local anesthesia before vascular access procedures: a randomized, double-blind, placebo-controlled study. Pain Med 2007;8:497-502
113. Wallace MS, Kopecky EA, Ma T, et al. Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers. Reg Anesth Pain Med 2010;35:507-13
114. Singer AJ, Taira BR, Chisena EN, et al. Warm lidocaine/tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial. Ann Emerg Med 2008;52:41-7
115. Ruetzler K, Sima B, Mayer L, et al. Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial access: a double-blind, randomized trial. Br J Anaesth 2012;109:790-6
116. Ravishankar N, Elliot SC, Beardow Z, et al. A comparison of Rapydan(R) patch and Ametop(R) gel for venous cannulation. Anaesthesia 2012;67:367-70
117. Sawyer J, Febbraro S, Masud S, et al. Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lidocaine/prilocaine cream (EMLA) for topical anaesthesia before vascular access. Br J Anaesth 2009;102:210-15
118. Murthy SN, Sammeta SM, Bowers C. Magnetophoresis for enhancing transdermal drug delivery:mechanistic studies and patch design. J Control Rel 2010;148:197-203